A carregar...
Determinants of esophageal varices bleeding in patients with advanced hepatocellular carcinoma treated with sorafenib
BACKGROUND AND AIMS: Sorafenib is the standard of care for patients with advanced hepatocellular carcinoma (HCC), yet treatment safety may be challenged by portal hypertension. We therefore assessed the prevalence, risk factors and clinical consequences of esophageal varices (EVs) in sorafenib-treat...
Na minha lista:
| Publicado no: | United European Gastroenterol J |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4924436/ https://ncbi.nlm.nih.gov/pubmed/27403302 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640615615041 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|